About biOasis Technologies Inc.

This author has not yet filled in any details.
So far biOasis Technologies Inc. has created 102 blog entries.
25 Jun,2017

biOasis Appoints Catherine London, Executive Vice President, Head of Corporate Communications and Investor Relations

By | 2017-06-25T19:01:30+00:00 Sunday, June 25, 2017|2017 Press Releases, Corporate Press Releases|

Download this as a PDF June 26, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) welcomes Catherine London as executive vice president, head of corporate communications and investor relations, effective immediately. London will report to Dr. Mark Day, president and chief executive officer of biOasis. In this newly created position, London will have responsibility for [...]

15 Jun,2017

biOasis Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities

By | 2017-06-15T12:00:22+00:00 Thursday, June 15, 2017|2017 Press Releases, Corporate Press Releases|

Download this as a PDF June 15, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) announced today it has engaged FreeMind Group to assist the Company pursue non-dilutive funding opportunities globally. The biOasis Transcend technology has been demonstrated to transport several different drug modalities (e.g., antibodies, enzymes, small molecules) across the blood-brain barrier (BBB) and [...]

14 Jun,2017

biOasis CEO Dr. Mark Day Releases Details of Corporate Plans in Message to Shareholders

By | 2017-06-15T09:08:10+00:00 Wednesday, June 14, 2017|2017 Press Releases, Corporate Press Releases|

Download this as a PDF June 14, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) Dr. Mark Day, chief executive officer, has issued a message to shareholders detailing plans for the advancement of the Transcend Platform and the company’s in-house programs. To the Shareholders of biOasis Technologies Inc.: As the new CEO of biOasis, I [...]

08 Jun,2017

biOasis to Present at The Global Chinese Financial Forum – Shanghai Conference 2017

By | 2017-06-08T21:40:47+00:00 Thursday, June 8, 2017|2017 Press Releases, Corporate Press Releases|

Download this as a PDF June 8, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) announced today that Dr. Mark Day, the chief executive officer of biOasis, will present at the Global Chinese Financial Forum (GCFF) - Shanghai Conference 2017, in Shanghai, China, on June 22, 2017. biOasis Board Chairman, Rob Hutchison, will attend the [...]

04 Jun,2017

biOasis to Present at the 16th International Postgraduate Course on Lysosomal Storage Disorders

By | 2017-06-04T22:45:24+00:00 Sunday, June 4, 2017|2017 Press Releases, Corporate Press Releases|

Download this as a PDF June 4, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) announced today that Dr. Mark Day, chief executive officer, will present at the 16th International Postgraduate Course on Lysosomal Storage Disorders, in Nierstein (Mainz), Germany on June 07 - 10, 2017. Dr. Day’s presentation, “Improving the Probability of Success in [...]

16 May,2017

biOasis Announces the Engagement of Mackie Research to Provide Market Making Services

By | 2017-06-04T22:44:42+00:00 Tuesday, May 16, 2017|2017 Press Releases, Corporate Press Releases|

THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES Download this as a PDF May 16th, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”), is pleased to announce that, subject to regulatory approval, it has retained Mackie Research Capital Corporation (“Mackie Research”) to initiate its market making service to provide market [...]

25 Apr,2017

biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director

By | 2017-05-16T18:32:17+00:00 Tuesday, April 25, 2017|2017 Press Releases, Corporate Press Releases|

THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES Download this as a PDF April 24th, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) has appointed Mark Day, Ph.D., as President and Chief Executive Officer of the Company, effective immediately. Dr. Day succeeds Mr. Rob Hutchison who will become Executive Chairman [...]

25 Apr,2017

biOasis Announces Investor Relations Service Agreement

By | 2017-05-16T18:32:37+00:00 Tuesday, April 25, 2017|2017 Press Releases, Corporate Press Releases|

THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES Download this as a PDF April 24, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) The Company announces that it has entered into an investor relations agreement (“Agreement”) with 551943 Alberta Ltd., operating as Colwell Capital Corp (“Colwell”), for a maximum term [...]

25 Apr,2017

BIOASIS ANNOUNCES GRANT OF STOCK OPTIONS AND RESTRICTED STOCK UNITS

By | 2017-05-16T18:32:45+00:00 Tuesday, April 25, 2017|2017 Press Releases, Corporate Press Releases|

THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES Download this as a PDF April 24, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) is pleased to announce that pursuant to the terms of its stock option plan (the “Option Plan”) and restricted stock units plan (the “RSU Plan”), the Company [...]

31 Mar,2017

biOasis Announces Oversubscription of Financing

By | 2017-05-16T18:32:53+00:00 Friday, March 31, 2017|2017 Press Releases, Corporate Press Releases|

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Download this as a PDF March 31st, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) is pleased to announce that further to its press release dated March 20, 2017, the Company’s non-brokered private placement (the "Private Placement"), is [...]